ArticleFrontiers in oncology2022

High Expression Levels of SIGLEC9 Indicate Poor Outcomes of Glioma and Correlate With Immune Cell Infiltration.

Heng Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.